Clinical Notes: HCV, Interferon, and Hedgehogs MedPage Today A drug with a mechanism of action similar to rituximab (Rituxan) but that may be more effective met its primary endpoint in the first part of a phase III trial, said its manufacturer. Compared with chlorambucil alone, the combination of obinutuzumab ... |
